NEW YORK STATE COMMON RETIREMENT FUND - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$99
-30.3%
12,726
+2.6%
0.00%
Q2 2023$142
-85.8%
12,400
+5314.8%
0.00%
Q2 2021$1,000
-98.4%
229
-98.2%
0.00%
Q1 2021$61,000
-33.7%
12,9000.0%0.00%
Q4 2020$92,000
-64.5%
12,900
-46.9%
0.00%
Q3 2020$259,000
-15.6%
24,3000.0%0.00%
Q2 2020$307,000
+113.2%
24,300
+54.8%
0.00%
Q1 2020$144,000
-58.4%
15,700
-36.7%
0.00%
Q4 2019$346,000
-21.2%
24,800
-2.7%
0.00%
-100.0%
Q3 2019$439,000
-36.7%
25,5000.0%0.00%0.0%
Q2 2019$694,000
+151.4%
25,500
+77.1%
0.00%
Q1 2019$276,000
+23.2%
14,400
-39.5%
0.00%
Q4 2018$224,000
-50.2%
23,8000.0%0.00%
-100.0%
Q3 2018$450,000
-3.2%
23,8000.0%0.00%0.0%
Q2 2018$465,000
+39.2%
23,800
+33.7%
0.00%
Q1 2018$334,000
+28.0%
17,800
+13.4%
0.00%
Q4 2017$261,000
-7.4%
15,700
+14.6%
0.00%
Q3 2017$282,000
+161.1%
13,700
+13.2%
0.00%
Q2 2017$108,000
-32.5%
12,100
-0.0%
0.00%
Q1 2017$160,000
+3.9%
12,101
+0.0%
0.00%
Q4 2016$154,000
+6.2%
12,1000.0%0.00%
Q3 2016$145,000
+353.1%
12,100
+317.2%
0.00%
Q2 2016$32,000
+28.0%
2,9000.0%0.00%
Q1 2016$25,0002,9000.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 7,891,176$154,194,00051.35%
Trustees of Princeton University 203,638$3,979,0004.13%
Casdin Capital, LLC 1,135,000$22,178,0003.10%
GREAT POINT PARTNERS LLC 730,010$14,264,0001.98%
BB BIOTECH AG 2,532,641$49,488,0001.43%
Aevitas Wealth Management, Inc. 73,323$1,433,0001.40%
Patriot Financial Group Insurance Agency, LLC 64,256$1,256,0001.34%
Virtus ETF Advisers LLC 37,502$733,0000.65%
Eventide Asset Management 703,425$13,745,0000.57%
THOMPSON DAVIS & CO., INC. 11,951$234,0000.56%
View complete list of VOYAGER THERAPEUTICS INC shareholders